Unichem Laboratories Share Price
Start SIP in Unichem Laboratories
Start SIPUnichem Laboratories Performance
Day Range
- Low 646
- High 671
52 Week Range
- Low 396
- High 695
- Open Price671
- Previous Close669
- Volume80327
Unichem Laboratories Investment Rating
-
Master Rating:
-
Unichem Laboratories has an operating revenue of Rs. 1,728.14 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of -4% needs improvement, ROE of -2% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 18% and 28% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 390 | 399 | 362 | 334 | 347 | 310 |
| Operating Expenses Qtr Cr | 350 | 369 | 343 | 341 | 338 | 319 |
| Operating Profit Qtr Cr | 40 | 31 | 19 | -7 | 8 | -9 |
| Depreciation Qtr Cr | 26 | 25 | 26 | 27 | 27 | 28 |
| Interest Qtr Cr | 1 | 2 | 2 | 4 | 2 | 3 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 21 | -115 | 69 | -31 | -16 | -144 |
Unichem Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹601.31
- 50 Day
- ₹576.81
- 100 Day
- ₹557.25
- 200 Day
- ₹523.35
- 20 Day
- ₹594.20
- 50 Day
- ₹566.71
- 100 Day
- ₹558.18
- 200 Day
- ₹522.05
Unichem Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 671.37 |
| Second Resistance | 683.63 |
| Third Resistance | 696.27 |
| RSI | 70.73 |
| MFI | 90.61 |
| MACD Single Line | 12.91 |
| MACD | 22.12 |
| Support | |
|---|---|
| First Support | 646.47 |
| Second Support | 633.83 |
| Third Supoort | 621.57 |
Unichem Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 90,190 | 3,151,239 | 34.94 |
| Week | 300,054 | 6,544,169 | 21.81 |
| 1 Month | 88,816 | 2,406,904 | 27.1 |
| 6 Month | 51,399 | 1,838,550 | 35.77 |
Unichem Laboratories Result Highlights
Unichem Laboratories Synopsis
NSE-Medical-Diversified
Unichem Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1442.17 Cr. and Equity Capital is Rs. 14.08 Cr. for the Year ended 31/03/2024. Unichem Laboratories Ltd. is a Public Limited Listed company incorporated on 22/08/1962 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1962PLC012451 and registration number is 012451.| Market Cap | 4,640 |
| Sales | 1,485 |
| Shares in Float | 2.11 |
| No of funds | 44 |
| Yield | 0.73 |
| Book Value | 2.02 |
| U/D Vol ratio | 1.7 |
| LTDebt / Equity | 2 |
| Alpha | 0.14 |
| Beta | 0.63 |
Unichem Laboratories Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 70.22% | 70.22% | 70.22% | 70.21% |
| Mutual Funds | 10.14% | 9.77% | 9.03% | 8.56% |
| Insurance Companies | 0.22% | 0.23% | 0.23% | 0.23% |
| Foreign Portfolio Investors | 0.89% | 0.9% | 0.84% | 0.83% |
| Financial Institutions/ Banks | 0.03% | 0.03% | 0.03% | 0.03% |
| Individual Investors | 14.81% | 15.13% | 15.63% | 15.8% |
| Others | 3.69% | 3.72% | 4.02% | 4.34% |
Unichem Laboratories Management
| Name | Designation |
|---|---|
| Dr. Prakash A Mody | Chairman, Non Ind & Non Exe Director |
| Mr. Pabitrakumar Bhattacharyya | Managing Director |
| Mr. Pranay Godha | Non Exe.Non Ind.Director |
| Ms. Priti Puri | Independent Director |
| Mr. Anand Kusre | Independent Director |
| Mr. Arun Todarwal | Independent Director |
Unichem Laboratories Forecast
Price Estimates
Unichem Laboratories Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results | |
| 2024-05-22 | Audited Results | |
| 2024-02-05 | Quarterly Results | |
| 2023-11-01 | Quarterly Results | |
| 2023-07-14 | Quarterly Results |
Unichem Laboratories FAQs
What is Share Price of Unichem Laboratories ?
Unichem Laboratories share price is ₹659 As on 18 September, 2024 | 02:33
What is the Market Cap of Unichem Laboratories ?
The Market Cap of Unichem Laboratories is ₹4640.4 Cr As on 18 September, 2024 | 02:33
What is the P/E ratio of Unichem Laboratories ?
The P/E ratio of Unichem Laboratories is -76.6 As on 18 September, 2024 | 02:33
What is the PB ratio of Unichem Laboratories ?
The PB ratio of Unichem Laboratories is 2 As on 18 September, 2024 | 02:33